EX-10.11
Zoar Ltd
16,982 total material contract exhibits.
Zoar Ltd
Zoar Ltd
REVOLVING PROMISSORY NOTE
(Document Security Systems, INC
promissory note insrument WITH, or Between, affiliates)
REVOLVING LOAN COMMITMENT:
| Loan Date: | December 31, 2020 |
| Maturity Date: | December 31, 2021 |
| Amount: | $1,059,229 |
| Borrower: | Impact BioMedical, Inc. |
| Borrower Address: | 6 Framark Drive, Victor, NY 14564 |
| Lender: | Document Security Systems, Inc. |
| Lender Address: | 6 Framark Drive, Victor, NY 14564 |
** **
…
Zoar Ltd
Zoar Ltd
Zoar Limited (f.k.a Dr Ashleys Limited)
1504, 15th Floor, Peninsula Square
18 Sung On Street, Hung Hom,
Kowloon, Hong Kong
[date], 2026
[Name]
I/C/O Zoar Limited
1504, 15th Floor, Peninsula Square
18 Sung On Street, Hung Hom,
Kowloon, Hong Kong
| Re: | Director Offer Letter |
Dear [Name],
Zoar Limited (f.k.a Dr Ashleys Limited), a Cayman Islands company (the “Company”), is pleased to offer you a position as a member of its Board of Directors (the “Board”). We believe your background and experience will be a significant asset to the Company and we look forward to your participation on the Board. Should you choose to accept this position as a member of the Board, this letter agreement (the “Agreement”) shall constitute an agreement between you and the Company and contains all the terms and conditions relating to the services you agree to provide to the Company.
…
Zoar Ltd
SHARE EXCHANGE AGREEMENT
THIS SHARE EXCHANGE AGREEMENT, dated as of February 12, 2026 (the “Agreement”), is made by and among Dr Vishys SIA Limited (f.k.a. as Rupus Global Limited), a Hong Kong company (“Dr Vishys”), Kanans Visvanats (a.k.a. Kannan Vishwanattah), a Latvian citizen (the “Shareholder”), Dr Ashleys Bio Labs Limited, a Cayman Islands exempted company (“Dr Ashleys Cayman”). Each of Dr Vishys, the Shareholder, and Dr Ashleys Cayman is referred as a “Party” and collectively as the “Parties” hereinunder.
RECITALS
WHEREAS, as of the date of this Agreement, Dr Vishys, with 117,030,000 issued and outstanding ordinary shares with no par value, and Dr Ashleys Cayman, with 100 issued and outstanding ordinary shares, US$0.0001 par value per share, are both wholly owned by Dr Ashleys Shareholder;
** **
…
Zoar Ltd
** **
EMPLOYMENT AGREEMENT
** **
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of _____, 2026, by and between Zoar Limited, a Cayman Islands exempted company incorporated with limited liability (the “Company”), and [●] (the “Executive”), to be effective as of the Effective Date (as defined below). Certain capitalized terms are defined in Section 9 of this Agreement.
WHEREAS, the Executive possesses certain experience and expertise that qualifies the Executive to provide the direction and leadership required by the Company; and
WHEREAS, pursuant to the written board resolution of the Company dated [●], the board of directors of the Company has authorized and approved the appointment of the Executive as the [title] (the “Position”) effective on [●], 2026 (the “Effective Date”).
NOW, THEREFORE, in consideration of the mutual covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows:
| 1. | EMPLOYMENT |
…
Zoar Ltd
Zoar Ltd
Zoar Ltd
AMERICAN EAGLE OUTFITTERS INC
June 12, 2026
Ravi Thanawala Dear Ravi,
We are pleased to offer you a position with American Eagle Outfitters, Inc. or one of its subsidiaries or affiliates (collectively, the "Company") in New York, NY. This letter confirms the terms of the Company's offer with respect to your planned employment.
You will join the Company as Executive Vice President - Chief Financial Officer, reporting to Jay Schottenstein, Chief Executive Officer. In this capacity, you will be designated as the Company’s Principal Financial Officer for purposes of applicable federal securities laws and SEC regulations. Your duties will include executing all required officer certifications and SEC filings. You also will be designated as an Executive Officer of the Company under Rule 3b-7 of the Exchange Act, and your compensation will be disclosed as required for Named Executive Officers under applicable SEC rules. In this capacity, you will be subject to the reporting requirements and trading restrictions of Section 16 of the Exchange Act. The Company agrees to provide reasonable administrative assistance with y
…
AMERICAN EAGLE OUTFITTERS INC
This Transition Agreement (this “Agreement”) is made as of June 29, 2026, by and between American Eagle Outfitters, Inc. (the “Company”) and Michael Mathias (“Executive”).
WHEREAS, Executive is currently employed by the Company as its Executive Vice President and Chief Financial Officer;
WHEREAS, the Company and Executive have agreed that, effective as of August 3, 2026 (the “Effective Date”), Executive will resign as Executive Vice President and Chief Financial Officer and from all other officer positions and will remain employed by the Company in the role of Strategic Advisor to the Chief Executive Officer during the Transition Period (as defined below); and
WHEREAS, upon the expiration of the Transition Period, Executive will retire from the Company.
NOW, THEREFORE, in consideration of the mutual covenants and agreements herein, the parties agree as follows:
1.
Transition Period; Position; Duties.
a.
…
AMERICAN EAGLE OUTFITTERS INC
THIS AGREEMENT, dated as of the 12th day of June, 2026, is made by and between American Eagle Outfitters, Inc., a Delaware corporation (the “Company”) and the executive listed on the signature page (the “Executive”).
WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and
WHEREAS, the Company recognizes that its executives may be involved in evaluating or negotiating any offers, proposals or other transactions which could result in a Change in Control of the Company and believes that it is in the best interest of the Company and its stockholders for such executives to be in a position to be able to assess objectively and pursue aggressively the interests of the Company’s stockholders in making these evaluations and carrying on such negotiations; and
…